-
Posted: August 9th, 2022, 2:00pm GMT
Condition: Gallbladder Cancer Unresectable
Intervention: Radiation: chemoradiation
Sponsors: Sanjay Gandhi Postgraduate Institute of Medical Sciences; American Society of Clinical Oncology
Recruiting
-
Posted: August 5th, 2022, 2:00pm GMT
Conditions: Hepatocellular Cancer; Cholangiocarcinoma; Gallbladder Cancer; Pancreatic Cancer; Oesophageal Cancer; Stomach Cancer
Intervention:
Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Recruiting
-
Posted: August 1st, 2022, 2:00pm GMT
Conditions: Colon Adenocarcinoma; Rectal Adenocarcinoma; Gastric Adenocarcinoma; Pancreatic Adenocarcinoma; Hepatocellular Carcinoma; Adenocarcinoma of Biliary Tract; Gallbladder Adenocarcinoma
Interventions: Drug: Atezolizumab; Drug: Bevacizumab
Sponsors: Georgetown University; Genentech, Inc.; Natera, Inc.
Not yet recruiting
-
Posted: July 11th, 2022, 2:00pm GMT
Conditions: Pancreatic Cancer; Hepatocellular Cancer; Biliary Tract Cancer; Cholangiocarcinoma
Interventions: Biological: Durvalumab; Drug: Gemcitabine; Drug: Nab paclitaxel; Biological: Tremelimumab; Drug: Propranolol; Drug: Cisplatin
Sponsor: AHS Cancer Control Alberta
Not yet recruiting
-
Posted: June 24th, 2022, 2:00pm GMT
Condition: Gallbladder Adenocarcinoma
Intervention: Drug: HIPEC
Sponsor: West Virginia University
Not yet recruiting
-
Posted: June 3rd, 2022, 2:00pm GMT
Condition: Gallbladder Cancer
Intervention: Diagnostic Test: Next generation sequencing
Sponsor: Banaras Hindu University
Recruiting
-
Posted: April 11th, 2022, 2:00pm GMT
Conditions: Bile Duct Neoplasms; Gall Bladder Carcinoma
Intervention: Device: Radio frequency ablation
Sponsor: Asian Institute of Gastroenterology, India
Recruiting
-
Posted: March 17th, 2022, 2:00pm GMT
Conditions: Distal Bile Duct Adenocarcinoma; Gallbladder Carcinoma; Intrahepatic Cholangiocarcinoma; Metastatic Malignant Neoplasm in the Peritoneum; Stage IV Distal Bile Duct Cancer AJCC v8; Stage IV Intrahepatic Bile Duct Cancer AJCC v8; Stage IV Intrahepatic Cholangiocarcinoma AJCC v8; Stage IVB Gallbladder Cancer AJCC v8
Interventions: Drug: Cisplatin; Drug: Gemcitabine; Drug: Nab-paclitaxel; Other: Quality-of-Life Assessment; Other: Questionnaire Administration
Sponsors: City of Hope Medical Center; National Cancer Institute (NCI)
Recruiting
-
Posted: March 9th, 2022, 3:00pm GMT
Condition: Distal Malignant Biliary Obstruction
Intervention: Procedure: endoscopic biliary drainage
Sponsor: Istituto Clinico Humanitas Mater Domini
Recruiting
-
Posted: February 14th, 2022, 3:00pm GMT
Conditions: Biliary Tract Cancer (CCA); Intrahepatic Cholangiocarcinoma; Hilar Cholangiocarcinoma; Distal Cholangiocarcinoma; Gall Bladder Carcinoma
Interventions: Drug: Durvalumab; Drug: Tremelimumab; Drug: Capecitabine
Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Recruiting
-
Posted: February 14th, 2022, 3:00pm GMT
Conditions: Biliary Tract Neoplasms; Pancreatic Carcinoma; Gallbladder Cancer; Pancreatic Head Carcinoma
Intervention: Diagnostic Test: The level of CIN
Sponsors: Xinhua Hospital, Shanghai Jiao Tong University School of Medicine; Shanghai Zhongshan Hospital; Ruijin Hospital; Changhai Hospital; Shanghai Changzheng Hospital; Eastern Hepatobiliary Surgery Hospital; First Affiliated Hospital Xi'an Jiaotong University; Jiangsu Provincial People's Hospital; Third Affiliated Hospital, Sun Yat-Sen University; First Affiliated Hospital of Zhejiang University; The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School; Second Hospital of Jilin University; West China Hospital; Southwest Hospital, China; Affiliated Hospital of North Sichuan Medical College; Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Recruiting
-
Posted: January 18th, 2022, 3:00pm GMT
Conditions: Ovarian Neoplasms; Peritoneal Neoplasms; Fallopian Tube Neoplasms; Triple Negative Breast Neoplasms; HER2 Negative Breast Neoplasms; Hormone Receptor Positive Breast Neoplasms; Endometrial Neoplasms; Carcinoma, Non-Small-Cell Lung; Cholangiocarcinoma; Gallbladder Carcinoma
Intervention: Drug: SGN-B7H4V
Sponsor: Seagen Inc.
Recruiting
-
Posted: October 12th, 2021, 2:00pm GMT
Conditions: Solid Tumor, Adult; Pancreatic Ductal; Adenocarcinoma; Ovarian Serous Adenocarcinoma; Biliary Cancer Metastatic; Ovarian Serous Cystadenocarcinoma
Intervention: Drug: ZB131
Sponsor: ZielBio, Inc.
Recruiting
-
Posted: August 11th, 2021, 2:00pm GMT
Conditions: Bile Duct Cancer; Gall Bladder Cancer; Breast Cancer; Neuroendocrine Tumors; Ovarian Cancer; Pancreatic Adenocarcinoma; Soft Tissue Sarcoma; Vulvar Cancer; Prostate Cancer
Interventions: Drug: Atezolizumab; Drug: Tivozanib
Sponsors: University of Florida; Genentech, Inc.; Aveo Oncology Pharmaceuticals
Recruiting
-
Posted: July 21st, 2021, 2:00pm GMT
Conditions: Advanced Biliary Tract Cancer; Neuroendocrine Tumors; Female Reproductive System Neoplasm; MSI-H Solid Malignant Tumor
Interventions: Drug: Ipilimumab; Drug: Nivolumab
Sponsors: Olivia Newton-John Cancer Research Institute; Bristol-Myers Squibb
Recruiting
-
Posted: June 28th, 2021, 2:00pm GMT
Condition: Malignant Biliary Obstruction
Interventions: Procedure: Intraductal Radio-Frequency Ablation; Device: Biliary Stent Placement
Sponsors: University Hospitals Dorset NHS Foundation Trust; Aquilant Services; The Christie NHS Foundation Trust
Not yet recruiting
-
Posted: June 18th, 2021, 2:00pm GMT
Conditions: Metastatic Cancer; Foregut Carcinoid Tumor; Gastric Adenocarcinoma; Gallbladder Adenocarcinoma; Liver Cancer; GI Cancer; GI Carcinoma; Lung Cancer
Interventions: Drug: Standard of Care Chemotherapy; Procedure: Video-Assisted Thoracic Surgery (VATS); Procedure: Lobectomy; Radiation: Consolidative Radiation; Radiation: Ablation Treatment; Procedure: Resection or Excision; Procedure: Peritonectomy; Other: Transarterial Radioembolization
Sponsor: University of Chicago
Not yet recruiting
-
Posted: June 1st, 2021, 2:00pm GMT
Condition: Advanced Solid Tumours
Interventions: Drug: RXC004; Biological: Denosumab
Sponsor: Redx Pharma Plc
Recruiting
-
Posted: June 1st, 2021, 2:00pm GMT
Conditions: Cancer Pain; Visceral Pain; Gastrointestinal Neoplasms; Cancer of Gastrointestinal Tract; Small Intestine Cancer; Pancreas Cancer; Liver Cancer; Colon Cancer; Biliary Tract Cancer; Stomach Cancer; Rectum Cancer; Peritoneal Cancer; Gastrointestinal Cancer Metastatic; Gastrointestinal Cancers - Anus; Gastrointestinal Cancers - Stomach; Gastrointestinal Cancers - Colorectal; Gastrointestinal Cancers - Small Intestine; Small Intestine Cancer Stage III; Small Intestine Cancer Stage IV; Small Intestine Cancer, Recurrent; Pancreas Cancer, Stage III; Pancreas Cancer, Stage IV; Pancreas Cancer, Metastatic; Pancreas Cancer, Recurrent; Liver Cancer Stage IIIa; Liver Cancer Stage IIIb; Liver Cancer Stage IIIc; Liver Cancer Stage IV; Colon Cancer Stage III; Colon Cancer Stage IV; Stomach Cancer Stage III; Stomach Cancer Stage IV; Stomach Cancer Recurrent; Rectum Cancer, Recurrent; Gastrointestinal Cancers - Liver; Anal Cancer; Anal Cancer Stage III; Anal Cancer Stage IV; Anal Cancer Recurrent; Anal Cancer Metastatic; Anal Cancer, Stage IIIA; Anal Cancer, Stage IIIB; Appendix Cancer; Ampullary Cancer; Bile Duct Cancer; Bile Duct Cancer Stage III; Bile Duct Cancer Stage IV; Bile Duct Cancer Stage IVA; Bile Duct Cancer Stage IVB; Bile Duct Cancer Recurrent; Carcinoid Tumor; Carcinoid Tumor of Pancreas; Carcinoid Tumor of Large Intestine; Carcinoid Tumor of GI System; Carcinoid Tumor of Colon; Carcinoid Tumor of Liver; Carcinoid Tumor of Cecum; Carcinoid Tumor of Ileum; Carcinoid Tumor of Rectum; Carcinoid Tumor of the Small Bowel; Carcinoid Tumor of the Stomach; Large Intestine Cancer; Esophagus Cancer; Esophagus Cancer, Stage III; Esophagus Cancer, Stage IV; Esophagus Cancer, Recurrent; Gallbladder Cancer; Gallbladder Cancer Stage III; Gallbladder Cancer Stage IV; Gastric (Stomach) Cancer; Neuroendocrine Tumor; Peritoneum Cancer; Rectal Cancer; Esophagus Cancer, Stage I; Esophagus Cancer, Stage II; Gallbladder Cancer Stage I; Gallbladder Cancer Stage II; Bile Duct Cancer Stage I; Bile Duct Cancer Stage II
Intervention: Device: PICO G2 4k
Sponsors: Cedars-Sinai Medical Center; National Cancer Institute (NCI)
Recruiting
-
Posted: May 21st, 2021, 2:00pm GMT
Conditions: Biliary Tract Cancer; Neoadjuvant, Adjuvant and 1st Line
Intervention:
Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Recruiting
-
Posted: February 8th, 2021, 3:00pm GMT
Conditions: Advanced Solid Tumor; Cholangiocarcinoma; HER2-negative Breast Cancer; Triple Negative Breast Cancer; Bladder Cancer; Small-cell Lung Cancer; Prostate Cancer; Thyroid Cancer; Sarcoma; Gastric Cancer; Gallbladder Cancer
Interventions: Drug: TT-00420; Combination Product: Nab-Paclitaxel
Sponsor: TransThera Sciences (Nanjing), Inc.
Recruiting
-
Posted: February 5th, 2021, 3:00pm GMT
Conditions: Bile Duct Carcinoma; Gallbladder Carcinoma; Pancreatic Ductal Adenocarcinoma
Intervention: Procedure: Endoscopic Retrograde Cholangiopancreatography
Sponsors: M.D. Anderson Cancer Center; National Cancer Institute (NCI)
Recruiting
-
Posted: February 3rd, 2021, 3:00pm GMT
Conditions: Midgut Carcinoid Tumor; Biliary Stones
Interventions: Procedure: Primary tumor surgery; Procedure: Primary tumor surgery (bowel resection) combined with prophylactic cholecystectomy
Sponsor: Hospital Universitari de Bellvitge
Recruiting
-
Posted: January 13th, 2021, 3:00pm GMT
Conditions: Congenital Hyperinsulinism; Neuroblastoma; Parkinson Disease; Lewy Body Disease; Neuroendocrine Tumors; Brain Tumor
Interventions: Drug: 18F-DOPA; Drug: Furosemide Injection
Sponsor: University of Alberta
Recruiting
-
Posted: December 24th, 2020, 3:00pm GMT
Conditions: Solid Tumor; Gastric Cancer; Gastroesophageal Junction Adenocarcinoma; Esophageal Adenocarcinoma; Pancreatic Cancer; Biliary Tract Cancer; Cholangiocarcinoma; Metastatic Cancer
Interventions: Biological: BNT141; Drug: Nab-paclitaxel; Drug: Gemcitabine
Sponsor: BioNTech SE
Recruiting
-
Posted: September 23rd, 2020, 2:00pm GMT
Conditions: Biliary Tract Cancer; Cholangiocarcinoma; Gallbladder Cancer; Intrahepatic Cholangiocarcinoma; Perihilar Cholangiocarcinoma; Extrahepatic Cholangiocarcinoma; Hilar Cholangiocarcinoma; Distal Bile Duct Cancer
Intervention: Diagnostic Test: Multi-Platform Profiling with Organoid Drug Sensitivity Screening and ctDNA Monitoring
Sponsors: University of Washington; Natera, Inc.; SEngine Precision Medicine, Inc.
Recruiting
-
Posted: July 31st, 2020, 2:00pm GMT
Condition: Advanced Cancer
Intervention: Biological: TST001 injection
Sponsors: Mabspace Biosciences (Suzhou) Co., Ltd.; Beijing Cancer Hospital; First Affiliated Hospital of Zhejiang University; Fudan University; Henan Cancer Hospital; Second Affiliated Hospital, School of Medicine, Zhejiang University; Tianjin Medical University Cancer Institute and Hospital; First Affiliated Hospital Bengbu Medical College; The First People's Hospital of Jingzhou; Sixth Affiliated Hospital, Sun Yat-sen University; Beijing Friendship Hospital; Tianjin Medical University General Hospital; Hainan People's Hospital; Hubei Cancer Hospital; Jilin Provincial Tumor Hospital; Jinan Central Hospital; Liaoning Cancer Hospital & Institute; Sichuan Cancer Hospital and Research Institute; The Affiliated Hospital of Qingdao University; The First Affiliated Hospital of Zhengzhou University; The First Hospital of Jilin University; Second Affiliated Hospital of Nanchang University; Second Affiliated Hospital of Soochow University; West China Hospital; Fujian Cancer Hospital; Zhejiang Cancer Hospital; First Affiliated Hospital of Chongqing Medical University; Xuzhou Central Hospital; Suzhou Municipal Hospital; First Hospital of China Medical University; Fujian Medical University Union Hospital; Bristol-Myers Squibb
Recruiting
-
Posted: July 23rd, 2020, 2:00pm GMT
Conditions: Hepatocellular Cancer; Cholangiocarcinoma; Gallbladder Cancer; Pancreatic Cancer; Oesophageal Cancer; Stomach Cancer
Intervention: Diagnostic Test: FoundationOne®CDx and FoundationOne®Liquid
Sponsors: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest; Roche Pharma AG
Recruiting
-
Posted: July 10th, 2020, 2:00pm GMT
Condition: HER2-amplified Biliary Tract Cancers
Interventions: Drug: ZW25 (Zanidatamab); Diagnostic Test: In situ hybridization (ISH)-based companion diagnostic assay; Diagnostic Test: Immunohistochemistry (IHC)-based companion diagnostic assay
Sponsors: Zymeworks Inc.; BeiGene, Ltd.
Recruiting
-
Posted: June 24th, 2020, 2:00pm GMT
Conditions: Hepatocellular Carcinoma; Cholangiocarcinoma; Gallbladder Cancer; Biliary Tract Cancer; Liver Cancer; Precancerous Condition; Benign Hepatobiliary Disease; Healthy, no Evidence of Disease
Interventions: Other: Gene expression analysis; Other: Genomic analysis; Other: Protein expression analysis; Other: Proteomic profiling; Other: Polymerase chain reaction; Other: Mass spectrometry; Other: Immunohistochemistry; Other: Metabolomics profiling; Other: Methylation and epigenetic analysis; Other: Liquid biopsy analysis; Other: Laboratory biomarker analysis
Sponsors: Peking Union Medical College Hospital; OrigiMed; GeneCast Biotechnology Co., Ltd.; YuceBio Technology Co., Ltd.
Recruiting
-
Posted: April 27th, 2020, 2:00pm GMT
Condition: Gallbladder Cancer
Interventions: Combination Product: Shortened hydration time and dispensary of Akynzeo; Combination Product: Standard of care
Sponsors: Imperial College Healthcare NHS Trust; Chugai Pharma UK Limited
Recruiting
-
Posted: January 31st, 2020, 3:00pm GMT
Conditions: Gallstones; Gastric Cancer
Intervention: Procedure: Resection
Sponsor: Hepatopancreatobiliary Surgery Institute of Gansu Province
Recruiting
-
Posted: December 18th, 2019, 3:00pm GMT
Condition: Biliary Tract Cancer
Interventions: Drug: CPI 613; Drug: Gemcitabine; Drug: Cisplatin
Sponsor: University of Michigan Rogel Cancer Center
Recruiting
-
Posted: November 15th, 2019, 3:00pm GMT
Conditions: Advanced Colorectal Carcinoma; Metastatic Colorectal Carcinoma; Stage IV Colorectal Cancer AJCC v8; Stage IVA Colorectal Cancer AJCC v8; Stage IVB Colorectal Cancer AJCC v8; Stage IVC Colorectal Cancer AJCC v8; Stage II Colon Cancer; Stage II Rectal Cancer; Stage III Colon Cancer; Stage III Rectal Cancer; Esophageal Cancer; Pancreatic Cancer; Bile Duct Cancer; Gastric Cancer; Gall Bladder Cancer; Small Bowel Adenocarcinoma
Interventions: Biological: Bevacizumab; Drug: Dasatinib; Drug: Fluorouracil; Drug: Leucovorin; Drug: Leucovorin Calcium; Drug: Oxaliplatin; Other: Quality-of-Life Assessment
Sponsor: Anne Noonan
Recruiting
-
Posted: October 21st, 2019, 2:00pm GMT
Condition: Primary Sclerosing Cholangitis
Interventions: Drug: Simvastatin 40mg; Drug: Placebo oral tablet
Sponsor: Annika Bergquist
Recruiting
-
Posted: November 7th, 2018, 3:00pm GMT
Condition: Cancer
Intervention: Biological: FP-1305 (bexmarilimab)
Sponsor: Faron Pharmaceuticals Ltd
Recruiting
-
Posted: August 16th, 2016, 2:00pm GMT
Condition: Gall Bladder Cancers
Interventions: Drug: Gemcitabine; Drug: Cisplatin; Radiation: Chemoradiation; Procedure: PETCECT; Procedure: Laparoscopy
Sponsor: Tata Memorial Hospital
Recruiting
-
Posted: June 23rd, 2014, 2:00pm GMT
Conditions: Cholangiocarcinoma; Gall Bladder Carcinoma
Interventions: Drug: Gemcitabine; Drug: Cisplatin; Drug: Capecitabine
Sponsors: Universitätsklinikum Hamburg-Eppendorf; Deutsche Krebshilfe e.V., Bonn (Germany); Cancer Research UK; Australasian Gastro-Intestinal Trials Group; Dutch Cancer Society
Recruiting